Expand ABEO Menu
ABEO MENU

ABEO Latest Press Releases

-- March 17, 2026 --

Abeona Therapeutics Reports Full Year 2025 Financial Results and Corporate Updates Globe Newswire 7:30 AM

-- March 9, 2026 --

Abeona Therapeutics Provides Business Update Highlighting Building Momentum in ZEVASKYN Commercial Launch Globe Newswire 7:30 AM

-- March 3, 2026 --

Abeona Therapeutics Announces Date of Fourth Quarter / Full Year 2025 Financial Results and Participation in Upcoming 2026 Leerink Global Healthcare Conference Globe Newswire 7:30 AM

-- February 9, 2026 --

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 10:04 AM

-- December 31, 2025 --

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 7:30 AM

-- December 15, 2025 --

Abeona Therapeutics Announces Appointment of Mohamad Tabrizi as Chief Business Officer Globe Newswire 7:30 AM

-- December 11, 2025 --

Abeona Therapeutics Announces New Qualified Treatment Center for ZEVASKYN in Texas Globe Newswire 7:30 AM

-- December 8, 2025 --

Abeona Therapeutics Announces First Patient Treatment with ZEVASKYN Gene Therapy Globe Newswire 7:30 AM

-- December 1, 2025 --

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 7:30 AM

-- November 12, 2025 --

Abeona Therapeutics Reports Third Quarter 2025 Financial Results and Corporate Updates Globe Newswire 7:30 AM

-- November 7, 2025 --

Abeona Therapeutics Announces Date of Third Quarter Financial Results and Upcoming Investor Conference Participation Globe Newswire 7:30 AM

-- November 3, 2025 --

Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 7:30 AM

-- October 30, 2025 --

Abeona Therapeutics Announces Permanent J-Code for ZEVASKYN (prademagene zamikeracel) Globe Newswire 10:45 AM
Market Data Delayed 15 Minutes